Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cells

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–17. doi:10.3322/caac.21332.
   PubMed Web of Science ®Google Scholar
• Reck M, Heigener DF, Mok T, Soria JC, Rabe KF. Management of non-small-cell lung cancer: recent developments. Lancet. 2013;382:709–719. doi:10.1016/S0140-6736(13)61502-0.
   PubMed Web of Science ®Google Scholar
• Messaritakis I, Politaki E, Kotsakis A, Dermitzaki E-K, Koinis F, Lagoudaki E, Koutsopoulos A, Kallergi G, Souglakos J, Georgoulias V, et al. Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer. PLoS One. 2017;12(7):e0181211. doi:10.1371/journal.pone.0181211.
   PubMed Web of Science ®Google Scholar
• Jie XX, Zhang XY, Xu CJ. Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: mechanisms and clinical applications. Oncotarget. 2017;8:81558–81571. doi:10.18632/oncotarget.18277.
   PubMedGoogle Scholar
• Massague J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature. 2016;529:298–306. doi:10.1038/nature17038.
   PubMed Web of Science ®Google Scholar
• Azevedo AS, Follain G, Patthabhiraman S, Harlepp S, Goetz JG. Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both? Cell Adh Migr. 2015;9:345–356. doi:10.1080/19336918.2015.1059563.
   PubMed Web of Science ®Google Scholar
• Akhtar M, Haider A, Rashid S, Paget’s A-NA. “Seed and soil” theory of cancer metastasis: an idea whose time has come. Adv Anat Pathol. 2019;26:69–74. doi:10.1097/PAP.0000000000000219.
   PubMed Web of Science ®Google Scholar
• Merino D, Weber TS, Serrano A, Vaillant F, Liu K, Pal B, Di Stefano L, Schreuder J, Lin D, Chen Y, et al. Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer. Nat Commun. 2019;10(1):766. doi:10.1038/s41467-019-08595-2.
   PubMed Web of Science ®Google Scholar
• Klotz R, Thomas A, Teng T, Han SM, Iriondo O, Li L, Restrepo-Vassalli S, Wang A, Izadian N, MacKay M, et al. Circulating tumor cells exhibit metastatic tropism and reveal brain metastasis drivers. Cancer Discov. 2020 Jan;10(1):86–103. doi:10.1158/2159-8290.CD-19-0384
   PubMed Web of Science ®Google Scholar
• Goldenberg DM, Pavia RA, Tsao MC. In vivo hybridisation of human tumour and normal hamster cells. Nature. 1974;250:649–651. doi:10.1038/250649a0.
   PubMed Web of Science ®Google Scholar
• Pawelek JM. Tumour cell hybridization and metastasis revisited. Melanoma Res. 2000;10:507–514. doi:10.1097/00008390-200012000-00001.
   PubMed Web of Science ®Google Scholar
• Gast CE, Silk AD, Zarour L, Riegler L, Burkhart JG, Gustafson KT, Parappilly MS, Roh-Johnson M, Goodman JR, Olson B, et al. Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Sci Adv. 2018;4(9):eaat7828. doi:10.1126/sciadv.aat7828.
   PubMed Web of Science ®Google Scholar
• Yilmaz Y, Lazova R, Qumsiyeh M, Cooper D, Pawelek J. Donor Y chromosome in renal carcinoma cells of a female BMT recipient: visualization of putative BMT-tumor hybrids by FISH. Bone Marrow Transplant. 2005;35:1021–1024. doi:10.1038/sj.bmt.1704939.
   PubMed Web of Science ®Google Scholar
• Lazova R, Laberge GS, Duvall E, Spoelstra N, Klump V, Sznol M, Cooper D, Spritz RA, Chang JT, Pawelek JM, et al. A melanoma brain metastasis with a donor-patient hybrid genome following bone marrow transplantation: first evidence for fusion in human cancer. PLoS One. 2013;8(6):e66731. doi:10.1371/journal.pone.0066731.
   PubMed Web of Science ®Google Scholar
• Chakraborty A, Lazova R, Davies S, Bäckvall H, Ponten F, Brash D, Pawelek J. Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient. Bone Marrow Transplantation. 2004;34(2):183–186. doi:10.1038/sj.bmt.1704547.
   PubMed Web of Science ®Google Scholar
• Pawelek JM, Chakraborty AK. Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer. 2008;8:377–386. doi:10.1038/nrc2371.
   PubMed Web of Science ®Google Scholar
• Kerbel RS, Lagarde AE, Dennis JW, Donaghue TP. Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor. Mol Cell Biol. 1983;3:523–538. doi:10.1128/MCB.3.4.523.
   PubMed Web of Science ®Google Scholar
• Busund LT, Killie MK, Bartnes K, Seljelid R. Spontaneously formed tumorigenic hybrids of Meth A sarcoma cells and macrophages in vivo. Int J Cancer. 2003;106:153–159. doi:10.1002/ijc.11210.
   PubMed Web of Science ®Google Scholar
• Larizza L, Schirrmacher V, Graf L, Pfluger E, Peres-Martinez M, Stohr M. Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage. Int J Cancer. 1984;34:699–707. doi:10.1002/ijc.2910340518.
   PubMed Web of Science ®Google Scholar
• Chakraborty AK, Sodi S, Rachkovsky M, Kolesnikova N, Platt JT, Bolognia JL, Pawelek JM. A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids.. Cancer Res. 2000;60:2512–2519.
   PubMed Web of Science ®Google Scholar
• Noubissi FK, Harkness T, Alexander CM, Ogle BM. Apoptosis-induced cancer cell fusion: a mechanism of breast cancer metastasis. Faseb J. 2015;29:4036–4045. doi:10.1096/fj.15-271098.
   PubMed Web of Science ®Google Scholar
• Lindstrom A, Midtbo K, Arnesson LG, Garvin S, Shabo I. Fusion between M2-macrophages and cancer cells results in a subpopulation of radioresistant cells with enhanced DNA-repair capacity. Oncotarget. 2017;8:51370–51386. doi:10.18632/oncotarget.17986.
   PubMedGoogle Scholar
• Zumsteg A, Baeriswyl V, Imaizumi N, Schwendener R, Ruegg C, Christofori G. Myeloid cells contribute to tumor lymphangiogenesis. PLoS One. 2009;4:e7067. doi:10.1371/journal.pone.0007067.
   PubMed Web of Science ®Google Scholar
• Seyfried TN, Huysentruyt LC. On the origin of cancer metastasis. Crit Rev Oncog. 2013;18:43–73. doi:10.1615/CritRevOncog.v18.i1-2.40.
   PubMedGoogle Scholar
• Del Fresno C, Garcia-Rio F, Gomez-Pina V, Soares-Schanoski A, Fernández-Ruíz I, Jurado T, Kajiji T, Shu C, Marín E, Gutierrez Del Arroyo A, et al. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J Immunol. 2009;182(10):6494–6507. doi:10.4049/jimmunol.0803350.
   PubMed Web of Science ®Google Scholar
• Lopez-Ayllon BD, Moncho-Amor V, Abarrategi A, de Cáceres II, Castro-Carpeño J, Belda-Iniesta C, Perona R, Sastre L. Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations. Cancer Medicine. 2014;3(5):1099–1111. doi:10.1002/cam4.291.
   PubMed Web of Science ®Google Scholar
• Ibrahim KE, Al-Mutary MG, Bakhiet AO, Khan HA. Histopathology of the liver, kidney, and spleen of mice exposed to gold nanoparticles. Molecules. 2018 Jul 25;23(8):1848.
   Web of Science ®Google Scholar
• Kotecha N, Krutzik PO, Irish JM. Web-based analysis and publication of flow cytometry experiments. Curr Protoc Cytom. 2010 Chapter 10: Unit10 17;53(1):10.17.1–10.17.24. doi:10.1002/0471142956.cy1017s53.
   Google Scholar
• Rider MA, Hurwitz SN, Meckes DG Jr. ExtraPEG: A polyethylene glycol-based method for enrichment of extracellular vesicles. Sci Rep. 2016;6:23978. doi:10.1038/srep23978.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676. doi:10.1016/j.cell.2006.07.024.
   PubMed Web of Science ®Google Scholar
• Boyette LB, Macedo C, Hadi K, Elinoff BD, Walters JT, Ramaswami B, Chalasani G, Taboas JM, Lakkis FG, Metes DM, et al. Phenotype, function, and differentiation potential of human monocyte subsets. PLoS One. 2017;12(4):e0176460. doi:10.1371/journal.pone.0176460.
   PubMed Web of Science ®Google Scholar
• Wang P, Wan WW, Xiong SL, Feng H, Wu N. Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer. Cell Death Discov. 2017;3:16105. doi:10.1038/cddiscovery.2016.105.
   PubMed Web of Science ®Google Scholar
• Zhao R, Chen M, Jiang Z, Zhao F, Xi B, Zhang X, Fu H, Zhou K. Platycodin-D induced autophagy in non-small cell lung cancer cells via PI3K/Akt/mTOR and MAPK signaling pathways. J Cancer. 2015;6(7):623–631. doi:10.7150/jca.11291.
   PubMed Web of Science ®Google Scholar
• Sainz B Jr., Carron E, Vallespinos M, Machado HL. Cancer stem cells and macrophages: implications in tumor biology and therapeutic strategies. Mediators Inflamm. 2016;2016:9012369. doi:10.1155/2016/9012369.
   PubMed Web of Science ®Google Scholar
• Pascual G, Avgustinova A, Mejetta S, Martín M, Castellanos A, Attolini CSO, Berenguer A, Prats N, Toll A, Hueto JA, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541(7635):41–45. doi:10.1038/nature20791.
   PubMed Web of Science ®Google Scholar
• Vilahur G. New role for CD36 in metastasis through fat intake. Cardiovasc Res. 2017;113:e16–e17. doi:10.1093/cvr/cvx075.
   PubMed Web of Science ®Google Scholar
• Helming L, Winter J, Gordon S. The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion. J Cell Sci. 2009;122:453–459. doi:10.1242/jcs.037200.
   PubMed Web of Science ®Google Scholar
• Ishii T, Mann GE. Redox status in mammalian cells and stem cells during culture in vitro: critical roles of Nrf2 and cystine transporter activity in the maintenance of redox balance. Redox Biol. 2014;2:786–794. doi:10.1016/j.redox.2014.04.008.
   PubMed Web of Science ®Google Scholar
• Hale JS, Otvos B, Sinyuk M, Alvarado AG, Hitomi M, Stoltz K, Wu Q, Flavahan W, Levison B, Johansen ML, et al. Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression. Stem Cells. 2014;32(7):1746–1758. doi:10.1002/stem.1716.
   PubMed Web of Science ®Google Scholar
• He C, Carter AB. The metabolic prospective and redox regulation of macrophage polarization. J Clin Cell Immunol. 2015;6(6):371.
   Google Scholar
• Colegio OR, Chu N-Q, Szabo AL, Chu T, Rhebergen AM, Jairam V, Cyrus N, Brokowski CE, Eisenbarth SC, Phillips GM, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014;513(7519):559–563. doi:10.1038/nature13490.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Kisugi R. Mechanisms of LDL oxidation. Clin Chim Acta. 2010;411:1875–1882. doi:10.1016/j.cca.2010.08.038.
   PubMed Web of Science ®Google Scholar
• Seo JW, Yang EJ, Yoo KH, Choi IH. Macrophage differentiation from monocytes is influenced by the lipid oxidation degree of low density lipoprotein. Mediators Inflamm. 2015;2015:235797. doi:10.1155/2015/235797.
   PubMed Web of Science ®Google Scholar
• Rattigan YI, Patel BB, Ackerstaff E, Sukenick G, Koutcher JA, Glod JW, Banerjee D. Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. Exp Cell Res. 2012;318(4):326–335. doi:10.1016/j.yexcr.2011.11.014.
   PubMed Web of Science ®Google Scholar
• Clawson GA, Matters GL, Xin P, Imamura-Kawasawa Y, Du Z, Thiboutot DM, Helm KF, Neves RI, Abraham T. Macrophage-tumor cell fusions from peripheral blood of melanoma patients. PLoS One. 2015;10(8):e0134320. doi:10.1371/journal.pone.0134320.
   PubMed Web of Science ®Google Scholar
• Ricciarelli R, Zingg JM, Azzi A. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation. 2000;102:82–87. doi:10.1161/01.CIR.102.1.82.
   PubMed Web of Science ®Google Scholar
• Wong CW, Lee A, Shientag L, Yu J, Dong Y, Kao G, Al-Mehdi AB, Bernhard EJ, Muschel RJ. Apoptosis: an early event in metastatic inefficiency.. Cancer Res. 2001;61:333–338.
   PubMed Web of Science ®Google Scholar
• Krzewski K, Coligan JE. Human NK cell lytic granules and regulation of their exocytosis. Front Immunol. 2012;3:335. doi:10.3389/fimmu.2012.00335.
   PubMed Web of Science ®Google Scholar
• Cubillos-Zapata C, Hernandez-Jimenez E, Avendano-Ortiz J, Toledano V, Varela-Serrano A, Fernández-Navarro I, Casitas R, Carpio C, Aguirre LA, García-Río F, et al. Obstructive sleep apnea monocytes exhibit high levels of vascular endothelial growth factor secretion, augmenting tumor progression. Mediators Inflamm. 2018;2018:7373921. doi:10.1155/2018/7373921.
   PubMed Web of Science ®Google Scholar
• Wang H, Franco F, Tsui Y-C, Xie X, Trefny MP, Zappasodi R, Mohmood SR, Fernández-García J, Tsai C-H, Schulze I, et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat Immunol. 2020;21(3):298–308. doi:10.1038/s41590-019-0589-5.
   PubMed Web of Science ®Google Scholar
• Welch DR, Hurst DR. Defining the hallmarks of metastasis. Cancer Res. 2019;79:3011–3027. doi:10.1158/0008-5472.CAN-19-0458.
   PubMed Web of Science ®Google Scholar
• Hunter KW, Crawford NP, Alsarraj J. Mechanisms of metastasis. Breast Cancer Res. 2008;10(Suppl 1):S2. doi:10.1186/bcr1988.
   PubMedGoogle Scholar
• Stopeck AT, Lipton A, Body -J-J, Steger GG, Tonkin K, de Boer RH, Lichinitser M, Fujiwara Y, Yardley DA, Viniegra M, et al. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol. 2010;28(35):5132–5139. doi:10.1200/JCO.2010.29.7101.
   PubMed Web of Science ®Google Scholar
• Steger GG, Bartsch R. Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion. Ther Adv Med Oncol. 2011;3(5):233–243. doi:10.1177/1758834011412656.
   PubMedGoogle Scholar
• Smith MR, Saad F, Oudard S, Shore N, Fizazi K, Sieber P, Tombal B, Damiao R, Marx G, Miller K, et al. Denosumab and bone metastasis–free survival in men with nonmetastatic castration-resistant prostate cancer: exploratory analyses by baseline prostate-specific antigen doubling time. J Clin Oncol. 2013;31(30):3800–3806. doi:10.1200/JCO.2012.44.6716.
   PubMed Web of Science ®Google Scholar
• Kim M-Y, Oskarsson T, Acharyya S, Nguyen DX, Zhang XHF, Norton L, Massagué J. Tumor self-seeding by circulating cancer cells. Cell. 2009;139(7):1315–1326. doi:10.1016/j.cell.2009.11.025.
   PubMed Web of Science ®Google Scholar
• Jia S, Zhang R, Li Z, Li J. Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer. Oncotarget. 2017;8:55632–55645. doi:10.18632/oncotarget.17184.
   PubMedGoogle Scholar
• Clawson G. The fate of fusions. Cells. 2018;8(1):13.
   Web of Science ®Google Scholar
• Manjunath Y, Porciani D, Mitchem JB, Suvilesh KN, Avella DM, Kimchi ET, Staveley-O'Carroll KF, Burke DH, Li G, Kaifi JT. Tumor-cell-macrophage fusion cells as liquid biomarkers and tumor enhancers in cancer. Int J Mol Sci. 2020;21(5):1872.
   Web of Science ®Google Scholar
• Lobb RJ, Lima LG, Moller A. Exosomes: key mediators of metastasis and pre-metastatic niche formation. Semin Cell Dev Biol. 2017;67:3–10. doi:10.1016/j.semcdb.2017.01.004.
   PubMed Web of Science ®Google Scholar